National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
NCI Drug Dictionary

alprazolam
A triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities. Alprazolam binds to a specific site distinct from the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) binding site on the benzodiazepine-GABA-A-chloride ionophore receptor complex located in the limbic, thalamic and hypothalamic regions of the central nervous system (CNS). This binding causes an allosteric modification of the receptor and enhances the affinity of GABA to the receptor leading to an increase in the frequency of chloride-channel opening events. This leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential and leads to a decrease in neuronal excitability. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Xanax
Foreign brand names:Apo-Alpzar
Nu-Alpraz

Previous:alpha fetoprotein plasmid DNA vaccine, alpha-1,3-galactosyltransferase-expressing allogeneic lung tumor cell vaccine, alpha-1,3-galactosyltransferase-expressing allogeneic pancreatic tumor cell vaccine, alpha-Gal glycosphingolipids, alpha-galactosylceramide-pulsed autologous dendritic cells
Next:alprostadil, Althose, altretamine, alum adjuvant, ALVAC(2) melanoma multi-antigen therapeutic vaccine